• Citer

Health-related quality of life and disease symptoms in postmenopausal women with hr+, her2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy

par Campone, Mario;Beck, Joseph Thaddeus;Gnant, Michael;Neven, Patrick;Pritchard, Kathleen;Bachelot, Thomas;Provencher, Louise;Rugo, Hope;Piccart-Gebhart, Martine ;Hortobagyi, Gabriel N.;Nunzi, Martina;Heng, Daniel Y C;Baselga, José;Komorowski, Anna;Noguchi, Shinzaburo;Horiguchi, Jun;Bennett, Lee;Ziemiecki, Ryan;Zhang, Jie;Cahana, Ayelet;Taran, Tetiana;Sahmoud, Tarek;Burris, Howard H.A.
Référence Current medical research and opinion, 29, 11, page (1463-1473)
Publication Publié, 2013-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Health-related quality of life and disease symptoms in postmenopausal women with hr+, her2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy
Auteur:	Campone, Mario; Beck, Joseph Thaddeus; Gnant, Michael; Neven, Patrick; Pritchard, Kathleen; Bachelot, Thomas; Provencher, Louise; Rugo, Hope; Piccart-Gebhart, Martine; Hortobagyi, Gabriel N.; Nunzi, Martina; Heng, Daniel Y C; Baselga, José; Komorowski, Anna; Noguchi, Shinzaburo; Horiguchi, Jun; Bennett, Lee; Ziemiecki, Ryan; Zhang, Jie; Cahana, Ayelet; Taran, Tetiana; Sahmoud, Tarek; Burris, Howard H.A.
Informations sur la publication:	Current medical research and opinion, 29, 11, page (1463-1473)
Statut de publication:	Publié, 2013-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Advanced breast cancer
	Everolimus
	Exemestane
	Health-related quality of life
	Hormone receptor positive
MeSH keywords:	Adult
	Aged
	Androstadienes -- adverse effects -- therapeutic use
	Antineoplastic Agents -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
	Breast Neoplasms -- drug therapy -- metabolism
	Disease Progression
	Disease-Free Survival
	Female
	Health Status
	Humans
	Immunosuppressive Agents -- therapeutic use
	Middle Aged
	Placebos -- therapeutic use
	Quality of Life
	Questionnaires
	Receptor, ErbB-2 -- metabolism
	Receptors, Estrogen -- metabolism
	Receptors, Progesterone -- metabolism
	Sirolimus -- adverse effects -- analogs & derivatives -- therapeutic use
	Treatment Outcome
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0300-7995
	info:doi/10.1185/03007995.2013.836078
	info:scp/84885758013
	info:pmid/23962028